CD47 and lymphoma: Lin and colleagues demonstrated that CD47 blockade ex vivo with TTI-621 (a fusion protein of an engineered SIRPα protein and human IgG1-Fc) on lymphoma cells triggered their phagocytosis by a broad subset of macrophages, including both the M1 and the M2 subtype.35